期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

瘦素基因-2548G/A多态性与抗精神病药物所致体重增加的关系进展 被引量：4

原文传递
导出
摘要 非典型抗精神病药物在治疗精神分裂症时常引起患者体重增加。瘦素是由肥胖基因编码的蛋白质,其作用主要是通过抑制摄食、促进脂肪分解、增加机体能量消耗来调节正常人的体重。本文就瘦素基因-2548G/A的变异与抗精神病药物所致体重增加之间的关系进行综述,来了解抗精神病药物所致体重增加的相关机制,并指导临床用药。
作者 张蓓蓓 陈晋东
机构地区 中南大学湘雅二医院精卫研究所
出处 《国际精神病学杂志》 2013年第3期173-175,共3页 Journal Of International Psychiatry
关键词 抗精神病药物 瘦素基因 体重增加
分类号 R749.05 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献14

  • 1Nasrallab H. A review of the effect of atypical antipsychotics on weight. Psyehoneuroendocrinology, 2003 ;28 ( Suppl 1 ) :83 -96.
  • 2Mammes O, Betoulle D, Aubert R, et al. Novel polymor- phisms in the 5' region of the LEP gene : association with lep- tin levels and response to low-calorie diet in human obesity. Diabetes, 1998 ; 47:487 -489.
  • 3Wang TN, Huang MC, Chang WT ,et al. G-2548A polymor- phism of the leptin gene is correlated with extreme obesity in Taiwan Residents aborigines. Obesity ,2006 ; 14 : 183-187.
  • 4Ellingrod VL, Bishop JR, Moline J, et al. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophre- nia. Psychopharmacol Bull. 2007 ;40:57-62.
  • 5Kang SG, Lee H J, Park YM, et al. Possible association be-tween the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Neuropsychopharmacol Biol Psychiatry, 2008;32(1) : 160-163.
  • 6Mou XD, Zhang ZJ, Zhang XR, et al. -2548G/A functional polymorphism in the promoter region of leptin gene and antip- sychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association. Zhong Nan Da Xue Xue Bao, 2008;33(4) : 316-320.
  • 7喻妍,赵靖平,吴仁容.瘦素基因-2548G/A多态性与抗精神病药物所致体重增加的关联分析[J].中国神经精神疾病杂志,2008,34(10):616-618. 被引量：11
  • 8Calarge CA,Ellingrod VL, Zimmerman B, et al. Leptin gene -2548G/A variants predict associated weight gain in children and adolescents. Psyehiatr Genet. 2009 ; 19 (6) : 320-327.
  • 9Hoffstedt J , Eriksson P , Mottagu-iTabar S, et al A polymor- phism in the leptin promoter region ( -2548G/A ) influences gene expression and adiposetissue secretion of leptin . Horm Metab Res. 2002;34(7) : 355-359.
  • 10Gregoor JG, Mulder H, Cohen D, et al. Combined HTR2C- LEP genotype as a determinant of obesity in patients using an- tipsyehotie medication. J Clin Psyehopharmaeol. 2010; 30 (6) : 702-725.

二级参考文献12

  • 1宋学勤,赵靖平,吕路线.首发精神分裂症患者利培酮治疗前后血浆瘦素和白细胞介素-6的研究[J].中国神经精神疾病杂志,2006,32(3):244-248. 被引量：5
  • 2杨可冰,卞清涛,邸晓兰.非典型抗精神病药物对患者体质量的影响[J].国际精神病学杂志,2007,34(3):187-189. 被引量：15
  • 3Mammes O, Betoulle D, Aubert R, et al. Association of the G- 2548A polymorphism in the 5'region of the LEP gene with overweight [J]. Ann Hum Genet, 2000, 64 (PtS) :391 -394.
  • 4LeStunff C, Bihan CL, Schork NJ, et al. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls [ J ]. Diabetes, 2000,49(12) :2196-2200.
  • 5Melkersson KI, Hulting AL, Brismar KE. Elevated levels of insu lin, leptin, and blood liplds in olanzaplne-treated patients with schizophrenia or related psychoses [ J ]. J Clin Psychiatry, 2000,61 (10) :742 -749.
  • 6Zhang YY, Proece R, Maffei M, et al. Positinal cloning of the mouse obese gene and its human homologue [J]. Nature, 1994, 372 (6505) :425 - 432.
  • 7Hoffstedt J, Eriksson P, Mottagui-Tabar S, et al. A polymorphism in the leptin promoter region (-2548G/A) influences gene expression and adipose tissue secretion of leptin [ J ]. Horm Metab Res, 2002, 34(7) :355 -359.
  • 8Templeman LA, Reynolds GP, Arranz B, et al. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug induced weight gain in Caucasian subjects with a firstepisode psychosis. Pharmacogenet Genomics, 2005, 15 (4) : 195- 200
  • 9Ellingrod VL, Perry PJ, Ringold JC, et al. Weight gain associated with the-759C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Gene, 2005, 134B(1):76-78.
  • 10Richards AA, Hickman IJ, Wang AY, et al. Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia. J Clin Psycho-pharmacol, 2006,26(3) :232 -237.

共引文献10

同被引文献22

  • 1Deng C. Effects of antipsychotic medications on appetite, weight, and insulin resistance. Endocrinol Metab Clin North Am. 2013; 42 (3): 545-563.
  • 2Ferno J, Varela L, Skrede S, et al. Olanzapine-induced hy- perphagia and weight gain associate with orexigenic hypotha- lamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One, 2011; 6 (6): e20571.
  • 3Jin H, Meyer JM, Mudaliar S, et al. Impact of atypical an- tipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr Res. 2008; 100 (1-3) : 70-85.
  • 4Zhang Q, He M, Deng C, et al. Hypothalamic ghrelin sig- nalling mediates olanzapine-induced hyperphagia and weight gain in female rats. Int J Neuropsyehopharmaeol, 2014; 17 (5) : 807-818.
  • 5Fonseka TM, Tiwari AK, Goncalves VF, et al. The role of genetic variation across IL-lbeta, IL-2, IL-6, and BDNF in antipsyehotic-indueed weight gain. World J Biol Psychia- try, 2015; 16 (1): 45-56.
  • 6Miron IC, Baroana VC, Popescu F, et al. Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders. Curr Health Sci J. 2014; 40 (1) : 12- 17.
  • 7He M, Zhang Q, Deng C, et al. Hypothalamic histamine H! receptor-AMPK signaling time-dependently mediates olanzap- ine-induced hyperphagia and weight gain in female rats. Psy- choneuroendocrinology, 2014; 42: 153-164.
  • 8Lian J, Huang XF, Pai N, et al. Preventing olanzapine-in- duced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment. PLoS One, 2014; 9 (8) : e104160.
  • 9Poyurovsky M, Fuchs C, Pashinian A, et al. Reducing an- tipsychotie-induced weight gain in schizophrenia: a double- blind placebo-controlled study of reboxetine-betahistine com- bination. Psychopharmacology ( Berl ), 2013 ; 226 ( 3 ) : 615-622.
  • 10Brand E J, Frydrychowicz C, Tiwari AK, et al. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain. Prog Neuropsy- chopharmacol Biol Psychiatry, 2012; 38 (2) : 134-141.

引证文献4

二级引证文献4

国际精神病学杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部